A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab
Clinical trial NCT03409458 · COMPLETED
Trial details
- NCT number
- NCT03409458
- Sponsor
- Promontory Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2022-06-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.